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Abstract The submitochondrial and subcellular distributions of
the carnitine-acylcarnitine translocase (CAC) have been studied.
CAC is enriched to a much lesser extent than the carnitine
palmitoyltransferases within the contact sites of mitochondria. A
high-abundance protein of identical molecular size as the
mitochondrial CAC that is immunoreactive with an anti-peptide
antibody raised against a linear epitope of mitochondrial CAC is
present in peroxisomes but not in microsomes. This suggests that
CAC is targeted to at least two different locations within the liver
cell and that acylcarnitine transport into peroxisomes is CAC
mediated.
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1. Introduction
It is well established that mitochondria have overt (outer
membrane) and latent (inner membrane) carnitine palmitoyl-
transferases (CPT). In conjunction with the carnitine-acylcar-
nitine translocase of the inner membrane (CAC, [1,2]) they
e¡ect the transfer of acyl moieties from the cytosol into the
mitochondrial matrix. The sensitivity of the overt, cytosol-
facing CPT (CPTo or CPT I) to malonyl-CoA inhibition
makes it an important regulatory locus for acylcarnitine for-
mation, and thus for the L-oxidation of fatty acids. We have
recently shown that both the overt and latent (CPTi or CPT
II) carnitine palmitoyltransferases are enriched within the con-
tact sites of mitochondria [3]. This submitochondrial distribu-
tion of the two enzymes at sites known to be important for
lipid tra⁄c between the cytosolic and intramitochondrial com-
partments [4], suggests that acylcarnitine formed by CPTo is
preferentially channelled to CPTi. We were interested, there-
fore, in establishing whether CAC is also enriched within the
contact sites, or whether its other functions (e.g. transport of
acetylcarnitine) necessitate its wider distribution within the
inner membrane.
It has become apparent relatively recently that peroxisomes
and microsomes also have overt and latent carnitine palmi-
toyltransferase activities [5^8]. These are assumed to be in-
volved in the transport of acyl moieties across these mem-
branes. As the overt and latent transferases of organelles
require the presence of a mechanism for the transport of
acylcarnitines across the membrane in order to ful¢l their
function, we carried out experiments to ¢nd out whether mi-
tochondrial CAC is also expressed in microsomes or perox-
isomes.
2. Materials and methods
2.1. Preparation of submitochondrial membrane fractions
Percoll-puri¢ed mitochondria (see below) were resuspended in 2.14
ml of 10 mM phosphate bu¡er (pH 7.4) and incubated on ice for 20
min, followed by the addition of 0.86 ml of 60% sucrose in 10 mM
phosphate bu¡er. The suspension was incubated for a further 20 min
on ice and then sonicated for three periods of 30 s, over a period of
3 min with constant cooling on ice, as described previously [3]. After a
low speed centrifugation (300Ug) to remove debris, the resulting
supernatant was layered on top of 10 ml of a continuous sucrose
gradient (0.82^1.71 M sucrose) and centrifuged for 16 h at 37 000
rpm in a swing-out rotor (Sorvall TH641) as described previously
[3]. Fractions collected by vertical displacement.
2.2. Preparation of subcellular fractions
Livers of 24 h-starved rats (200^220 g) were homogenised in me-
dium containing 300 mM sucrose, 5 mM Tris-HCl and 1 mM EGTA
(pH 7.4) and a cocktail of protease inhibitors (Boehringer Complete).
After centrifugation at 500Ug, a crude mitochondrial pellet was sedi-
mented from the supernatant by centrifugation at 5800Ug for 20 min.
This pellet was used to prepare puri¢ed mitochondria by Percoll den-
sity gradient centrifugation [9] and puri¢ed peroxisomes by Nycodenz
density gradient centrifugation [10]. Microsomes were prepared from
12 000 supernatants by centrifugation at 100 000Ug for 60 min.
2.3. Western blotting and enzyme assays
The protein components of the membrane fractions were separated
on 8% acrylamide Laemmli gels and blotted onto nitrocellulose, fol-
lowed by probing with appropriate antibodies. Detection of CPTs I
and II was performed using sheep anti-peptide (residues 428^441 of
rat liver CPT I) and anti-CPT II antibodies, respectively, as described
previously [3]. Porin was detected using mouse anti-human porin 3HL
(Calbiochem). CAC was detected by an anti-peptide antibody raised
in sheep against residues 96^110 of rat liver CAC. Secondary anti-
bodies conjugated to alkaline phosphatase and the 5-bromo-4-chloro-
3-indoyl phosphate/nitro blue tetrazolium system were used through-
out for detection. Quanti¢cation of the bands obtained was performed
using phosphorimage analysis (Molecular Dynamics).
Rotenone-insensitive cytochrome c-NADPH oxidoreductase (outer
membrane marker), adenylate kinase (inter membrane space marker)
and cytochrome c oxidase (inner membrane marker) were assayed as
described previously [3]. Total and membrane protein (after centrifu-
gation at 160 000Ug) were measured by the method of Lowry et al.
[11].
3. Results
3.1. Submitochondrial distribution of CAC
Separation of outer membrane, contact site and inner mem-
brane fractions from rat liver mitochondria on continuous
sucrose gradients is shown in Fig. 1a, together with the dis-
tribution of membrane protein (Fig. 1b). Characteristic distri-
butions of NADPH-cytochrome c oxidoreductase, porin and
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cytochrome oxidase were observed (cf. [3]). In Fig. 2a the
distribution of immunodetectable CAC is shown. It can be
seen that CAC is primarily distributed within the inner mem-
brane fraction, but that a smaller but discrete peak also occurs
within the contact site fraction of intermediate density. The
distributions of CPTs I and II observed for the same gradient
are shown in Fig. 2b. The greater enrichment of both CPTs
within contact sites compared to CAC is evident from Fig. 3
in which the abundance of the individual components of the
mitochondrial acylcarnitine transferase-translocase system are
expressed relative to the distributions of the outer and inner
membrane marker enzymes. (Values higher than 1.0 indicate
enrichment relative to the marker.) Fig. 3a shows that CPT I
and CAC are enriched respectively within the contact sites
and inner membrane fractions. When the distributions of
CPT II and CAC are expressed relative to cytochrome oxidase
(Fig. 3b) it is evident that whereas CPT II is highly enriched
within the contact sites (cf. [3]) CAC is distributed much more
uniformly relative to the inner membrane marker (values close
to unity throughout).
3.2. Subcellular distribution of CAC
A speci¢c antibody raised against a linear epitope of mito-
chondrial CAC as expected detected the protein in mitochon-
drial extracts (Fig. 4, lane 1) having the molecular size (ap-
prox. 33 kDa) anticipated from the deduced amino acid
sequence of the carrier [12]. A protein corresponding to an
identical molecular size was detected in peroxisomes (Fig. 4,
lane 3), but not in microsomes (lane 2) even when twice the
amount of protein was loaded onto the gel (lane 4). Quanti-
¢cation of the relative intensities of reaction of peroxisomal
and mitochondrial CAC indicates that the peroxisomal pro-
tein is present at a 1.5-fold higher speci¢c abundance (per mg
protein) than that in mitochondria. This is 10-fold higher than
that which can be accounted for by the low level of cross-
contamination of peroxisomes by mitochondria (Table 1).
Consequently, we conclude that CAC is highly expressed in
peroxisomes and mitochondria but not in microsomes.
4. Discussion
The previously described enrichment of CPT I and CPT II
within mitochondrial contact sites suggested that a degree of
channelling of long-chain acylcarnitines occurs between the
two enzymes. Other observations tend to support this conten-
tion. For example, there is evidence that carnitine generated
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Fig. 1. The distribution of three marker proteins and total mem-
brane protein in submitochondrial fractions separated by sucrose
density gradient centrifugation. a: Mitochondria prepared and puri-
¢ed on Percoll gradients (see Section 2) were subfractionated on
continuous sucrose density gradients. The relative activity or abun-
dance of rotenone-insensitive NADPH-cytochrome c reductase (7),
porin (b) and cytochrome c oxidase (a) in the di¡erent fractions is
shown. For each parameter, the value for the fraction showing the
highest activity/abundance is set at unity and the values for other
fractions are expressed relative to it. b: Distribution of membrane
protein in the di¡erent fractions. The values shown are from an ex-
periment representative of three separate preparations that gave
qualitatively similar results. OM, outer membrane; CS, contact
sites; IM, inner membrane.
Fig. 2. Distribution of carnitine acylcarnitine carrier, CPT I and
CPT II in submitochondrial fractions. Gradient distribution of the
speci¢c abundance (per mg membrane protein) of immunodetectable
(a) CAC and (b) CPT I (R) and CPT II (E). The value for the
fraction with the highest speci¢c abundance (per mg membrane pro-
tein) is set at unity. Values shown are for the same preparation
used for Fig. 1 and are representative of those obtained for three
preparations. OM, outer membrane; CS, contact sites; IM, inner
membrane.
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from long-chain acylcarnitines by CPT II does not equilibrate
with a larger pool of carnitine within the matrix, and is pref-
erentially used by CAC in exchange for further acylcarnitine
uptake by mitochondria [13,14]. Also, a mixture of CPT I and
CPT II has been isolated in a complex with L-oxidation en-
zymes and electron transport chain components [15], suggest-
ing that they may exist in a complex [16] in which channelling
of acylcarnitines to L-oxidation occurs. This raised the ques-
tion as to whether CAC is concentrated at contact sites to a
similar extent as CPT I and CPT II [3]. The present data show
that this is not the case. Although CAC is present in contact
site membranes, it is also uniformly distributed within the
inner membrane of mitochondria. Its submitochondrial distri-
bution is very similar to that of cytochrome oxidase, and
much less concentrated at the contact sites than CPT II.
The reason for this more uniform distribution of CAC may
be that it ful¢ls functions other than those linked to the trans-
port of acylcarnitine formed by CPT I. For example, a con-
siderable proportion of acylcarnitine esters formed in perox-
isomes after partial L-oxidation of very long-chain fatty acids
are transported into the mitochondria matrix for complete
oxidation [17]. Similarly, short-chain acylcarnitines (acetylcar-
nitine, propionylcarnitine) formed in peroxisomes during L-
oxidation there are known to be further metabolised by mi-
tochondria of rat liver [18] and yeast [19]. In the reverse di-
rection, it is well established that mitochondria have a high
capacity to form and release acetylcarnitine and other short-
chain carnitine esters formed through the activity of the ma-
trix located carnitine acetyltransferase (CAT). For example,
under ketogenic conditions, the liver is known to release ace-
tylcarnitine of mitochondrial origin into the circulation [20].
Therefore, CAC has to transport acylcarnitines that are nei-
ther necessarily generated by the CPT I nor used by CPT II
for the generation of intramitochondrial long-chain acyl-CoA.
We suggest that this wider role of CAC is re£ected in its more
generalised distribution within the mitochondria inner mem-
brane.
Acyl moieties need to be moved across intracellular mem-
branes for a wide range of cellular functions. However, ester-
i¢cation to CoA within the cytosol [21] renders the resulting
acyl-CoA esters impermeant through biological membranes.
The relatively recent description of pairs of carnitine palmi-
toyltransferases not only in mitochondria, but also in micro-
somes [5,6] and peroxisomes [7], has raised the prospect that
carriers that ful¢l the same function as the mitochondrial
CAC also exist in other organelles and that CAC itself may
be targeted to organelles other than mitochondria. In the
present study we found that a peroxisomal protein with an
identical molecular size to that of mitochondrial CAC (32.5
kDa [12]) was immunodetectable when Western blots were
probed with a speci¢c anti-peptide antibody raised against a
linear epitope of mitochondrial CAC. Its high level of expres-
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Fig. 3. Submitochondrial distributions of CAC, CPT I and CPT II
relative to outer and inner membrane markers. In (a) the relative
abundance of CAC (8) and CPT I (R) in each fraction is plotted
as a fraction of that of the outer membrane marker rotenone-insen-
sitive NADPH cytochrome c oxidoreductase. CPT I is highly en-
riched within the contact sites (values s 1.0) whereas CAC is much
more highly enriched within the inner membrane fraction. In (b) the
relative abundance of CAC (8) and of CPT II (b) in each fraction
is plotted as a fraction of that of cytochrome c oxidase (inner mem-
brane marker). CPT II is highly enriched within the contact site
fraction (values s 3.0), whereas CAC has a similar pro¢le to that
of cytochrome oxidase (values V1.0 throughout).
Fig. 4. Expression of CAC in peroxisomal membranes and mito-
chondria but not in microsomes. Mitochondria, microsomes and
peroxisomes were prepared as described in Section 2 (see also Table
1 for purity). Following SDS-PAGE electrophoresis of membrane
fractions and transfer onto nitrocellulose, the blots were probed
with anti-CAC peptide antibody (raised against residues 96^110).
Lanes 1, 2 and 3: 100 Wg protein of mitochondrial, microsomal and
peroxisomal fractions, respectively. Lane 4: 200 Wg microsomal pro-
tein. M, molecular weight markers of the sizes indicated.
Table 1
Marker enzyme activities in the preparations of Percoll-puri¢ed mitochondria, microsomes and Nycodenz-puri¢ed peroxisomes used for Western
blotting experiments
Mitochondria Microsomes Peroxisomes
Cytochrome c oxidase 1280 þ 120 5.0 þ 2.0 189.0 þ 56.9
NADPH-cytochrome c oxidoreductase 7.6 þ 2.2 72.3 þ 5.4 5.9 þ 3.8
Uricase 14.6 þ 3.6 8.3 þ 1.9 257.3 þ 35.9
See Section 2 for details of subcellular fractionation and membrane puri¢cation. Enzyme activities (nmol/min per mg protein) were measured at
30‡C. Values are for four di¡erent preparations.
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sion in peroxisomes was 10-fold higher than could be ac-
counted for by cross-contamination between the two subcel-
lular fractions. By contrast, no CAC could be detected in the
microsomal fraction. These observations suggest that CAC is
not limited to the mitochondrial inner membrane and that it
may be involved in the transfer of acylcarnitine esters across
the peroxisomal membrane. There is increasing evidence that
transfer of acyl moieties across the peroxisomal membrane is
carnitine-dependent in the intact cell [22,23]. It is noteworthy
that, in common with other members of the mitochondrial
anion carrier family [24,25] CAC is not proteolytically proc-
essed upon import into the mitochondrial inner membrane
[12]. The motif(s) responsible for targeting CAC (and other
carriers) to the mitochondrial inner membrane have not been
elucidated and no obvious sequences have emerged yet that
direct the targeting of proteins to the peroxisomal membrane
[26].
CAC is absent from microsomal membranes (Fig. 4). Re-
cent studies by Gooding et al. [27] have concluded that trans-
fer of acylcarnitines across the endoplasmic reticular mem-
brane is not carrier mediated but occurs by a pore
mechanism. Suggestions for a pore or channel of 5^8 Aî diam-
eter that allows the entry of metabolites across the endoplas-
mic reticular membranes have been made previously [28]. The
existence of such a pore may explain the absence of CAC
from this membrane system. However, acylcarnitine transfer
across the endoplasmic reticular membrane does occur [27]. In
tissues (like the liver) that secrete triacylglycerol-rich lipopro-
teins its functions may include the provision of acyl moieties
for the intra-lumenal endoplasmic reticular synthesis of tria-
cylglycerol [29,30].
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